OPV116910: A Randomized, Double-Blind, Placebo- Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Ofatumumab Injection for Subcutaneous Use in Subjects with Pemphigus Vulgaris.
One hundred and ninety newly minted MDs will become medical
residents of the Jacobs School of Medicine and Biomedical Sciences
at UB at 3:30 p.m. on June 27 in the Center for Tomorrow on UB's
A preliminary study by senior author Bianca Weinstock-Guttman,
MD, has heightened researchers’ understanding about which
adults with multiple sclerosis (MS) may be at a higher risk for
developing worsening MS.